- Home
- NBY vs IKT Comparison
NBY vs IKT Comparison
Compare NBY & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- IKT
- Stock Information
- Founded
- NBY 2000
- IKT 2008
- Country
- NBY United States
- IKT United States
- Employees
- NBY N/A
- IKT N/A
- Industry
- NBY
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- IKT Health Care
- Exchange
- NBY Nasdaq
- IKT Nasdaq
- Market Cap
- NBY 3.5M
- IKT N/A
- IPO Year
- NBY 2007
- IKT 2020
- Fundamental
- Price
- NBY $0.63
- IKT $1.47
- Analyst Decision
- NBY
- IKT Strong Buy
- Analyst Count
- NBY 0
- IKT 1
- Target Price
- NBY N/A
- IKT $15.00
- AVG Volume (30 Days)
- NBY 7.7M
- IKT 1.1M
- Earning Date
- NBY 11-07-2024
- IKT 11-12-2024
- Dividend Yield
- NBY N/A
- IKT N/A
- EPS Growth
- NBY N/A
- IKT N/A
- EPS
- NBY N/A
- IKT N/A
- Revenue
- NBY $13,884,000.00
- IKT $79,570.00
- Revenue This Year
- NBY N/A
- IKT N/A
- Revenue Next Year
- NBY $26.04
- IKT N/A
- P/E Ratio
- NBY N/A
- IKT N/A
- Revenue Growth
- NBY 4.06
- IKT N/A
- 52 Week Low
- NBY $0.07
- IKT $0.80
- 52 Week High
- NBY $6.30
- IKT $3.82
- Technical
- Relative Strength Index (RSI)
- NBY 44.88
- IKT 65.66
- Support Level
- NBY $0.64
- IKT $1.15
- Resistance Level
- NBY $0.70
- IKT $1.88
- Average True Range (ATR)
- NBY 0.05
- IKT 0.15
- MACD
- NBY -0.00
- IKT 0.03
- Stochastic Oscillator
- NBY 0.00
- IKT 46.05
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.